Contact
Please use this form to send email to PR contact of this press release:
Tetra Bio-Pharma Announces PPP002 Program Update Following Type B Meeting with U.S. FDA
TO:
Please use this form to send email to PR contact of this press release:
Tetra Bio-Pharma Announces PPP002 Program Update Following Type B Meeting with U.S. FDA
TO: